Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,137 | -1,450 | -714 | -4,243 | -3,862 |
| Depreciation Amortization | 33 | 23 | 11 | N/A | N/A |
| Income taxes - deferred | -242 | -173 | -96 | N/A | N/A |
| Accounts receivable | 1 | 2 | 3 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 94 | N/A | N/A | N/A |
| Other Working Capital | 702 | 415 | 229 | 2,602 | 2,347 |
| Other Operating Activity | 475 | 132 | 41 | 156 | 138 |
| Operating Cash Flow | $-1,168 | $-958 | $-526 | $-1,485 | $-1,377 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 314 | 109 | 0 | 0 | 0 |
| Investing Cash Flow | $314 | $109 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 132 | 382 | 313 | N/A | N/A |
| Debt Issued | 692 | 606 | 50 | 1,110 | 1,113 |
| Debt Repayment | -157 | -177 | -13 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 450 | 450 |
| Financing Cash Flow | $667 | $812 | $350 | $1,560 | $1,563 |
| Exchange Rate Effect | -3 | -4 | 0 | N/A | N/A |
| Beginning Cash Position | 407 | 350 | 350 | 19 | 19 |
| End Cash Position | 217 | 309 | 174 | 93 | 205 |
| Net Cash Flow | $-190 | $-41 | $-176 | $75 | $186 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,168 | -958 | -526 | -1,485 | -1,377 |
| Free Cash Flow | -1,168 | -958 | -526 | -1,485 | -1,377 |